vs
NN INC（NNBR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
NN INC的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$104.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -12.0%，领先396.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -7.0%）
NN集团是NN投资伙伴与荷兰国家保险的母公司，旗下荷兰国家保险是荷兰规模最大的保险与资产管理机构之一。集团总部设于荷兰海牙，鹿特丹办事处坐落于代尔夫特门大厦，该大厦2009年之前一直是荷兰最高摩天楼，除此之外集团在荷兰埃德也设有办事处。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NNBR vs RIGL — 直观对比
营收规模更大
NNBR
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出22.9%
-1.7%
净利率更高
RIGL
高出396.0%
-12.0%
两年增速更快
RIGL
近两年复合增速
-7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.7M | $69.8M |
| 净利润 | $-12.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -9.9% | 33.2% |
| 净利率 | -12.0% | 384.0% |
| 营收同比 | -1.7% | 21.2% |
| 净利润同比 | 40.2% | 1769.2% |
| 每股收益（稀释后） | $-0.35 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NNBRRIGL
| Q4 25 | $104.7M | $69.8M | ||
| Q3 25 | $103.9M | $69.5M | ||
| Q2 25 | $107.9M | $101.7M | ||
| Q1 25 | $105.7M | $53.3M | ||
| Q4 24 | $106.5M | $57.6M | ||
| Q3 24 | $113.6M | $55.3M | ||
| Q2 24 | $123.0M | $36.8M | ||
| Q1 24 | $121.2M | $29.5M |
净利润NNBRRIGL
| Q4 25 | $-12.5M | $268.1M | ||
| Q3 25 | $-6.7M | $27.9M | ||
| Q2 25 | $-8.1M | $59.6M | ||
| Q1 25 | $-6.7M | $11.4M | ||
| Q4 24 | $-21.0M | $14.3M | ||
| Q3 24 | $-2.6M | $12.4M | ||
| Q2 24 | $-2.2M | $-1.0M | ||
| Q1 24 | $-12.5M | $-8.2M |
毛利率NNBRRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率NNBRRIGL
| Q4 25 | -9.9% | 33.2% | ||
| Q3 25 | -2.2% | 40.9% | ||
| Q2 25 | -1.4% | 60.1% | ||
| Q1 25 | -4.5% | 23.9% | ||
| Q4 24 | -15.8% | 28.9% | ||
| Q3 24 | -3.3% | 25.4% | ||
| Q2 24 | -1.7% | 1.2% | ||
| Q1 24 | -3.9% | -23.6% |
净利率NNBRRIGL
| Q4 25 | -12.0% | 384.0% | ||
| Q3 25 | -6.4% | 40.2% | ||
| Q2 25 | -7.5% | 58.6% | ||
| Q1 25 | -6.3% | 21.5% | ||
| Q4 24 | -19.7% | 24.9% | ||
| Q3 24 | -2.3% | 22.5% | ||
| Q2 24 | -1.8% | -2.8% | ||
| Q1 24 | -10.3% | -27.9% |
每股收益（稀释后）NNBRRIGL
| Q4 25 | $-0.35 | $14.11 | ||
| Q3 25 | $-0.23 | $1.46 | ||
| Q2 25 | $-0.26 | $3.28 | ||
| Q1 25 | $-0.23 | $0.63 | ||
| Q4 24 | $-0.52 | $0.82 | ||
| Q3 24 | $-0.13 | $0.70 | ||
| Q2 24 | $-0.12 | $-0.06 | ||
| Q1 24 | $-0.34 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $34.0M | $391.5M |
| 总资产 | $440.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NNBRRIGL
| Q4 25 | $11.4M | $155.0M | ||
| Q3 25 | $12.2M | $137.1M | ||
| Q2 25 | $9.5M | $108.4M | ||
| Q1 25 | $11.7M | $77.1M | ||
| Q4 24 | $18.1M | $77.3M | ||
| Q3 24 | $12.4M | $61.1M | ||
| Q2 24 | $13.7M | $49.1M | ||
| Q1 24 | $20.6M | $49.5M |
总债务NNBRRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NNBRRIGL
| Q4 25 | $34.0M | $391.5M | ||
| Q3 25 | $49.6M | $117.6M | ||
| Q2 25 | $59.5M | $81.9M | ||
| Q1 25 | $67.3M | $18.6M | ||
| Q4 24 | $74.5M | $3.3M | ||
| Q3 24 | $106.6M | $-14.6M | ||
| Q2 24 | $108.4M | $-29.9M | ||
| Q1 24 | $116.1M | $-31.7M |
总资产NNBRRIGL
| Q4 25 | $440.8M | $513.6M | ||
| Q3 25 | $451.0M | $242.5M | ||
| Q2 25 | $460.8M | $206.7M | ||
| Q1 25 | $460.7M | $176.0M | ||
| Q4 24 | $456.9M | $164.0M | ||
| Q3 24 | $483.1M | $139.4M | ||
| Q2 24 | $497.2M | $128.4M | ||
| Q1 24 | $512.8M | $126.5M |
负债/权益比NNBRRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-3.3M | — |
| 自由现金流率自由现金流/营收 | -3.2% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-7.2M | — |
8季度趋势，按日历期对齐
经营现金流NNBRRIGL
| Q4 25 | $-1.5M | $22.0M | ||
| Q3 25 | $11.2M | $24.0M | ||
| Q2 25 | $-696.0K | $30.5M | ||
| Q1 25 | $-3.3M | $-893.0K | ||
| Q4 24 | $6.7M | $14.5M | ||
| Q3 24 | $5.0M | $21.7M | ||
| Q2 24 | $-1.3M | $302.0K | ||
| Q1 24 | $712.0K | $-5.0M |
自由现金流NNBRRIGL
| Q4 25 | $-3.3M | — | ||
| Q3 25 | $7.7M | — | ||
| Q2 25 | $-4.4M | — | ||
| Q1 25 | $-7.3M | — | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-4.9M | — | ||
| Q1 24 | $-4.7M | — |
自由现金流率NNBRRIGL
| Q4 25 | -3.2% | — | ||
| Q3 25 | 7.4% | — | ||
| Q2 25 | -4.1% | — | ||
| Q1 25 | -6.9% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | -1.2% | — | ||
| Q2 24 | -4.0% | — | ||
| Q1 24 | -3.9% | — |
资本支出强度NNBRRIGL
| Q4 25 | 1.8% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 4.5% | — |
现金转化率NNBRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NNBR
| Automotive | $53.1M | 51% |
| Power Solutions | $45.5M | 43% |
| Other End Market | $4.7M | 4% |
RIGL
暂无分部数据
